DIETARY_SUPPLEMENT · Unmapped registry intervention
sulforaphane
Find medicine records ·
Find other trials using this name
Clinical trial
A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia
NCT02880462
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
sulforaphaneDIETARY_SUPPLEMENT
placeboOTHER
Sponsors & collaborators
Central South Universitylead sponsor
Stanley Medical Research Institutecollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02880462 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.